Article Data

  • Views 1536
  • Dowloads 137

Original Research

Open Access

Inhaled dry salt micro particles in the treatment of bronchopulmonary dysplasia: a five case series report


1Marie Curie“ Emergency Hospital for Children, Bucharest, Romania

2“Carol Davila” University of Medicine and Pharmacy, Bucharest Romania

DOI: 10.22514/SV132.112017.13 Vol.13,Issue 2,November 2017 pp.85-89

Published: 06 November 2017

*Corresponding Author(s): CATALIN G CIRSTOVEANU E-mail: cirstoveanu


Background. Despite current medical ad-vances, to this day there is no single medi-cal intervention to effectively prevent or treat bronchopulmonary dysplasia (BPD) in both preterm and term infants. Along with protective ventilation strategies, vari-ous drugs are being used or are being re-searched at this very moment, with the sole purpose of improving the general outcome for these patients. Inhaled dry salt micro particles therapy is now one of them. Materials and methods. This report pre-sents five patients, diagnosed with severe BPD. All of them received, complemen-tary to classical BPD management and respiratory support, continuous inhaled dry salt micro particles, via SaltMed car-tridges, for a period of 12 to 30 days. After only 24 hours of administration, we were able to observe a significant improvement in respiratory function and dynamics. It was possible to use a lower fraction of in-spired oxygen (FiO2), mean airway pres-sure (MAP) and peak inspiratory pressure (PIP) in all mechanically ventilated pa-tients. Higher tidal volumes were recorded and we observed improvement in oxygen-ation indexes.

Conclusion. Continuously inhaled dry salt micro particles, administered complemen-tary to classic BPD management, could improve respiratory and overall morbid-ity and mortality in infants with any form of BPD. Further study of these possible effects is needed, as there is no data pub-lished on this matter so far.


bronchopulmonary dysplasia (BPD), inhaled dry salt micro particles, oxy-genation index (OI), fraction of inspired ox-ygen (FiO2), mean airway pressure (MAP).

Cite and Share

NINE LUMINITA,CATALIN G CIRSTOVEANU,ALEXANDRA I ISTRATE –BARZAN,BARASCU ILEANA,STEFAN MANOLACHE,MIHAELA BIZUBAC,ALINA GAIDUCHEVICI. Inhaled dry salt micro particles in the treatment of bronchopulmonary dysplasia: a five case series report. Signa Vitae. 2017. 13(2);85-89.


1. Stark AR, Redding G. Pathogenesis and clinical features of bronchopulmonary dysplasia. UpToDate, Wolters Kluwer

2. Mourani PM, Abman SH. Pulmonary vascular disease in bronchopulmonary dysplasia: pulmonary hypertension and beyond. Curr Opin Pediatr 2013 Jun;25(3):329-37.

3. Stoll BJ, Hansen NI, Bell EF, Shankaran S, Laptook AR, Walsh MC, et al. National Institute of Child Health and Human Development Neonatal Research Network. Neonatal outcomes of extremely preterm infants from the NICHD Neonatal Research Network.

4. Pediatrics 2010;126(3):443.

5. Walsh MC, Szefler S, Davis J, Allen M, Van Marter L, Abman S, et al.

6. Summary proceedings from the bronchopulmonary dysplasia group. Pediatrics 2006;117(3 Pt 2):S52.

7. Ann R Stark, Richard Martin, Gregory Redding. Prevention of bronchopulmonary dysplasia, UpToDate, Wolters Kluwer

8. Ann R Stark, Richard Martin, Gregory Redding. Management of bronchopulmonary dysplasia, UpToDate, Wolters Kluwer

9. Bancalari E, Wilson-Costello D, Iben SC. Management of infants with bronchopulmonary dysplasi in Nort America. Early Hum Dev 2005;81(2):171-9.

10. Shinwell ES, Portnov I, Meerpohl J, Karen T, Bassler D. Use of inhaled costicosteroids for the prevention and/orbronchopulmonary dysplasia in preterm infants: asystematic review protocol. Sys Rev 2015 Sept 25;4(1):127.doi:10.1186/s 13643-015-0108-1

11. Abman SH, Groothius JR. Pathophysiology and treatment of bronchopulmonary dysplasia. Pediatr Clin Nort Am 1994;41(2):277-315.

12. Jasmine Shani Pharma D, Stephanie Phelps Pharma D. Nebulized Furosemide in the treatment of bronchopulmonary dysplasia in preterm infants. J Peditr Pharmacol Ther 2011;16(1):14-22.

13. Stelmach I, Jerzynska J, Bobrowska M, Brzozowska A, Majak P, Kuna P. The effect of inhaled heparin on airway responsiveness to metacholine in asthmatic children. Pol Arch Med Wewn 2001 Jul :106(1);567-72.

14. Gandia F, Rouatbi S, Lotiri I, Guenard H, Tabka Z. Inhaled magnesium floride reverse bronchospasma. J Smooth Muscle Res 2010;46(3):157-64.

15. Zhao W, Rouatbi S, Tabka Z, Guenard H. Inhaled sodium floride decreses airway resposiveness to acetylcholine analogs in vivo. Respir Physiol Neurobiol 2002 Aug 1;131(3):245-53.

Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,200 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Chemical Abstracts Service Source Index The CAS Source Index (CASSI) Search Tool is an online resource that can quickly identify or confirm journal titles and abbreviations for publications indexed by CAS since 1907, including serial and non-serial scientific and technical publications.

Index Copernicus The Index Copernicus International (ICI) Journals database’s is an international indexation database of scientific journals. It covered international scientific journals which divided into general information, contents of individual issues, detailed bibliography (references) sections for every publication, as well as full texts of publications in the form of attached files (optional). For now, there are more than 58,000 scientific journals registered at ICI.

Geneva Foundation for Medical Education and Research The Geneva Foundation for Medical Education and Research (GFMER) is a non-profit organization established in 2002 and it works in close collaboration with the World Health Organization (WHO). The overall objectives of the Foundation are to promote and develop health education and research programs.

Scopus: CiteScore 1.0 (2022) Scopus is Elsevier's abstract and citation database launched in 2004. Scopus covers nearly 36,377 titles (22,794 active titles and 13,583 Inactive titles) from approximately 11,678 publishers, of which 34,346 are peer-reviewed journals in top-level subject fields: life sciences, social sciences, physical sciences and health sciences.

Embase Embase (often styled EMBASE for Excerpta Medica dataBASE), produced by Elsevier, is a biomedical and pharmacological database of published literature designed to support information managers and pharmacovigilance in complying with the regulatory requirements of a licensed drug.

Submission Turnaround Time